期刊文献+

胱抑素C与心血管疾病关系 被引量:4

下载PDF
导出
摘要 胱抑素C(cystatin C,Cys-C)是1961年首先由Clausen于脑脊液中发现。Cys—C是半胱氨酸蛋白酶抑制剂家族中的重要成员之一,其在所有的有核细胞中均有表达,其主要生理作用是参与细胞内外蛋白水解的调控,从而使细胞免受不适当的内源性或外源性蛋白酶水解,在以往的研究认为Cys—C是评价肾功能肾小球滤过率(glomerular filtration rate,GFR)的最理想的指标之一。近年来国内外的动物实验和临床研究发现Cys.C与心血管疾病的发生有密切关系。为此本文在此对Cys—C与心血管疾病的相关研究进展综述如下。
出处 《内科》 2011年第5期480-482,共3页 Internal Medicine
  • 相关文献

参考文献20

  • 1Suzuki Y, Matsushita K, Yoshida T, et al. Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification [ J ]. Rinsho Byori ,2011,59 (4) :345 - 351.
  • 2Royakkers AA, Korevaar JC, van Suijlen JD, et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy[ J ]. Intensive Care Med, 2011,37 ( 3 ) : 493 - 501.
  • 3Zahran A, Qureshi M, Shoker A. Comparison between creatinine and cystatin C-based GFR equations in renal transplantation [ J ]. Nephrol Dial Transplant,2007,22 (9) :2659 - 2668.
  • 4Barka T, van der Noen H. Expression of the cysteine proteinaseinhibitor cysta-tin C gene in rat heart: use of digoxigenin-labeled probes generated by polymer-ase chain reaction directly for in situ and northern blot hybridizations [ J ]. Histochem Cytochem, 1993, 41 (12) : 1863 - 1867,.
  • 5Lindhoh JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of smafi abdominal aortic aneurysms [ J]. Br J Surg,2001,88 ( 11 ) : 1472 - 1475.
  • 6Eriksson P, DeguchHi, SamnegardA, et al. Human evidence that the cystatin C gene is imp licated in focalp rogression of coronary artery disease[ J]. ArteriosclerThromb Vasc Bio1,2004,24 ( 3 ) :551 - 557.
  • 7Koenig W, Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events : more than simply a marker of glomerular filtration rate [ J ]. Clin Chem,2005,51 ( 2 ) : 321 - 327.
  • 8黄飞雄,吴晓峰.胱抑素C与冠心病的病变程度相关性研究[J].河北医学,2010,16(6):691-693. 被引量:16
  • 9葛长江,任芳,吕树铮,柳弘,宋现涛,陈欣,孟康,吴小凡,苑飞,金泽宁,李红,季凤清.血浆胱抑素C对冠心病的临床预测价值[J].中华急诊医学杂志,2010,19(3):273-276. 被引量:45
  • 10李国栋,李凌,赵晓燕.冠心病患者血清胱抑素C、尿酸、血浆脂蛋白(a)水平的变化及其临床意义[J].实用医学杂志,2011,27(4):615-617. 被引量:38

二级参考文献59

共引文献193

同被引文献65

  • 1孙晓慧.血清胱抑素C测定在疾病监测中的应用[J].医学综述,2006,12(7):443-445. 被引量:46
  • 2万榕,葛爱敏,王海燕,高美钦.原发性乳腺癌组织蛋白酶B和Cystatin M的表达[J].中国组织化学与细胞化学杂志,2006,15(6):613-616. 被引量:6
  • 3万楠,王璐,罗军等.胱抑素C对急性蔻脉综合征患者的预后评估价值[J].国家检验医学杂志,2011,32(8):906-908.
  • 4Zahran A,Qureshi M,Shoker A.Comparison between creatinine and cystatin C-based GFR equations in renal transplantation [J]. Nephrol Dial Transplant, 2007,22 (9) : 2659-2668.
  • 5Ix JH,Shlipak MG,Chertow GM,et al. Association of Cystatin C With mort-ality, cardiovascular events, and incident heart failure among Per- sons with coro-nary heart disease:data from the Heart and Soul Study[J]. Circulation, 2007,115 (2) : 173-179.
  • 6Sarnak MJ,Katz R,Stehman-Breen CO,et al. Cystatin C concentration as a risk factor for heart failure in older-adults [J]. Ann InternMed, 2005,142(7) :497-505.
  • 7Shlipak M G,Samak MG,Katz R,et al. Cystatin C and mortality in el- derly persons with heart failure[J]. JACC, 2005,45 (18):268-271.
  • 8Cornwall GA,Hsia N.A new subgroup of the family 2 cystatins[J].Mol Cell Endocrinol,2003,200(1-2):1-8.
  • 9LaImanach G,Naudin C,Lecaille F,et al.Kininogens:More thancysteine protease inhibitors and kinin precursors[J],J Biochimie,2010,92(11):1568-1579.
  • 10Cudic M,Fields GB.Extracellular proteases as targets for drug de-velopment[J].Curr Protein Pept Sci,2009,10(4):297-307.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部